Pharmaceutical decision support consultancy, Lifescience Dynamics, wins Queen’s Award for Enterprise for International Trade

[London, 21st April 2016] Lifescience Dynamics, a London headquartered decision support management consultancy, has been awarded the prestigious Queen’s Award for Enterprise 2016 for International Trade. The business’ global network of opinion leaders, payers, researchers and expert consultants provides the pharmaceutical and life sciences industry with ‘unrivalled’ ‘strategic insight and foresight to assist with difficult decision making, in what are often complex and uncertain marketplaces.
In the heavily regulated pharmaceutical environment, Lifescience Dynamics has the ability to engage with a vast, global network of experts to determine market opportunities – the type of market insight and intelligence that pharmaceutical companies cannot directly gather themselves.
“The success of the business is down to the team’s ability to gather market data and intelligence to deliver actionable and impactful recommendations that are impartial, independent and considered,” said Lifescience Dynamics’ President, Rafaat Rahmani. “We are enablers that allow the world’s pharmaceutical businesses to see what’s around the corner.”

A changing healthcare environment
With so few blockbuster drugs on the horizon and many key disease areas well served by generics, innovation in the pharmaceutical market now focuses on precision and targeted medicine including biologics, regenerative and gene therapies.

“These novel treatments are expensive to discover, develop and produce, and it’s often uncertain who, how, and when anyone will pay for them,” says Rahmani. “In these increasingly niche and disparate markets, our pharmaceutical and biotech clients require a trusted partner for guidance and are increasingly reliant on deep and reliable market intelligence to ensure a smooth and successful introduction of new patents.”

Business growth
The company has seen exponential growth; having doubled in size from 2014 to 2015; and 2016 is predicted to grow at a similar rate. New offices are planned for US expansion in Boston, Princeton and Chicago.
“It is an absolute honour to be acknowledged with the Queen’s Award,” says Rahmani. “We compete on a global level every day, and we are winning.”
The success of Lifescience Dynamics’ recent growth correlates with the emphasis it places on hiring and training the best staff in the world. 75% of the organisation have PhDs and are recruited from the international pool of talent that is attracted to the UKs top universities. Rahmani attributes the fact that the UK and London is home to 10 of the top 100 universities, as a crucial success factor.

-ENDS-

Lifescience Dynamics is a decision support firm helping life sciences companies (pharmaceutical, biotechnology, diagnostics and medical devices) with strategic insight and foresight to improve their assumptions, enabling them to make better decisions.
Since its inception in 2004, the firm has earned its reputation not only for providing actionable insights but also for their invaluable ability to see around the bend. It is 100% independently owned and run by a team who consider customer satisfaction to be their core driver.

Their complementary competencies lie at the intersection of their three practice areas:
• Market research (qualitative and quantitative)
• Competitive intelligence (primary and secondary research)
• Market access, pricing and reimbursement

Rafaat Rahmani, Presdient of Lifescience Dynamics
In the summer of 2004, Rafaat founded Lifescience Dynamics. He had a vision of what would make an effective global decision support service, dedicated exclusively to pharmaceutical and biotechnology industries. It would have to be the best in class market research, competitive intelligence and market access, combined with first-rate people and a business model that met their clients’ global insight and foresight requirements. Lifescience Dynamics is privileged to boast an extraordinary worldwide customer base, with teams across the globe supporting clients of all sizes, from top 20 pharmaceutical companies through to smaller niche pharma and biotech firms. Rafaat prides himself in his dedication to his clients: “Revenue is important, but customer experience is even more crucial” is a motto reflected in everything the company does.

ROAD Communications
Voysey House
Barley Mow Passage
Chiswick
London
W4 4PH

This release was published on openPR.